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Foreword
For many women, emergency contraceptive pills (ECPs) offer an opportunity to prevent unintended
pregnancy following contraceptive method failure, rape or unprotected sex. Access to this safe, effective
option remains an essential element of women’s quality reproductive healthcare. However, ECPs remain
inaccessible across much of the world, as both supply and demand constraints undermine potential
clients’ ability to effectively use the method. This is particularly true in developing countries, where
limited commodity supplies, provider competency, public awareness, and misinformation routinely
coalesce to restrict the availability of ECPs. While ECPs have been introduced on a pilot basis in many
countries, their effective integration into both the public and private sectors has lagged in the face of
competing priorities. Successful interventions are guided by the principle that provision of ECPs is not
exclusively the responsibility of government family planning programs, and so seek to mainstream
delivery of ECPs by developing linkages with private sector providers and pharmacies, the HIV/AIDS
sector, and sexual assault services.
As with the introduction of most contraceptive methods that are new to a national program, the
process of successfully introducing ECPs into a country’s health care system is a complex and usually
protracted undertaking. This handbook is designed to provide step-by-step guidance for introducing and
mainstreaming ECPs within a variety of country contexts, in a manner that will be responsive to their
diverse needs and resource availability.
Production of this handbook was a collaborative effort between two projects of the Population Council’s
Reproductive Health Program: the Frontiers in Reproductive Health (FRONTIERS) project, funded by
USAID; and the ECafrique network, funded by the William and Flora Hewlett Foundation. It synthesizes
systematically documented programming practices drawn from a range of experiences in Africa, Asia,
and Latin America and the Caribbean over the past decade. The handbook has been compiled from four
unpublished reviews conducted by FRONTIERS (Muteshi and Keesbury 2007; Fernández and Vernon 2007;
Khan and Hossain 2007; Fernández et al. 2008) and from selected documents that provide complementary
guidance specific to the delivery of ECPs after their introduction and mainstreaming (e.g. PATH 2004;
Pathfinder 2007).
The intended audience for this handbook includes reproductive health (RH) program managers and
government and NGO policy makers. It can be used in countries where ECPs are not currently available,
as well as in contexts where the intention is to expand or mainstream access to existing ECP services. The
handbook:

recognizes the different needs of diverse segments of the population, and places additional
emphasis on targeting ECP services to “special groups,” which include rape survivors and
adolescents.

seeks to present an overall process that can be adapted to specific contexts and that is based on
documented successful experiences in a range of contexts.

guides policymakers and program managers through the continuum of ECP programming: from
needs assessments and operations research, to registration, to training, logistics, and ultimately
mainstreaming through nationwide scaling-up.
The handbook contains four sections:
Introduction and Background describes the existing situation of ECP programming around the globe.
Addressing the Needs of Specific Populations describes programming approaches designed for specific
populations.
Introducing and Mainstreaming ECPs describes five chronological steps for making ECP programming an
integral component of a national RH program.
The Bibliography lists useful resources for ECP programming.
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Introduction and Background
What is emergency contraception?
Emergency contraception (EC) is the term
given to contraceptive methods that can be
used by women in the first few days following
unprotected intercourse to prevent an unplanned
pregnancy (WHO 1998). EC should not be
recommended or used as a regular contraceptive
method. Emergency Contraceptive Pills (ECPs)
contain higher doses of the hormones used in
oral contraceptive pills. ECPs are effective in
preventing pregnancy when taken within 120
hours (five days) of unprotected sex, although
they are more effective the earlier they are taken.
ECPs are sometimes inaccurately called “the
morning after pill.”

Why are ECPs important?
ECPs provide a unique opportunity for
preventing pregnancy after unprotected
sex that no other contraceptive method
can provide.

ECPs can reduce the incidence of
unintended pregnancy, which may
otherwise result in an unsafe abortion.

ECPs are an important element in
post-rape care as well as an essential
component of reproductive health.

When does a woman need to use
ECPs?
ECPs are used after unprotected sex. This can
include the following situations:

when no contraceptive method has been

either one or two pills. If a two-pill
dose is used (0.75mg each), these may
be taken together or individually no
more than 12 hours apart.
2. Combined regimen of progestin and
estrogen (also known as the Yuzpe
method): at least 100mcg of ethinyl
estradiol and 500mcg of levonorgestrel
taken as a first dose within 120 hours
of unprotected intercourse, followed
by a second dose 12 hours later. This
regimen can be made by choosing
appropriate birth control pills and
calculating the number of pills
needed for each dose.
3. Progestin-only oral contraceptive
pills (OCPs): taken as a first dose of 20
pills within 120 hours of unprotected
intercourse, followed by a second dose
of 20 pills 12 hours later. This ECP
option is not generally recommended
due to the large number of pills
required, but can be a back-up option
in the absence of the other options.
A WHO multi-center randomized trial in ten
developed and developing countries found a
single 1.5 mg dose of levonorgestrel to be as
effective in reducing the risk of pregnancy as two
0.75 mg doses taken 12 hours apart. Side effects
did not differ between the regimens (von Hertzen
et al. 2002). According to the International
Consortium for Emergency Contraception
(ICEC), “providers should advise women to take
a single 1.5 mg dose of the levonorgestrel-only
ECP regimen” (ICEC 2003a). Option #1 simplifies
ECP use, but if not available, options #2 and #3
should be considered.

used;

when a condom breaks;
when a woman forgets to take oral
contraceptive pills for two or more days,
or delays a scheduled injectable for more
than two weeks; or

when a woman is raped/coerced into sex
and is not currently using contraception.

ECP options
1. Dedicated progestin-only ECPs
(specifically formulated and packaged
ECP product): 1.5mg levonorgestrel
taken in a single dose within 120
hours of unprotected intercourse, in

Efficacy and side effects of ECPs
The efficacy of ECPs in preventing pregnancy is
lower than the efficacy of regular contraceptive
methods. The figures below reflect the risk
of pregnancy in the 72 hour period following
unprotected intercourse.
Progestin-only:

Reduces the risk of pregnancy for that
single act of intercourse by 60-90 percent
(WHO et al 2005).

Side-effects: nausea in 23 percent of
women and vomiting in 6 percent (WHO
1998).



Combined estrogen and progestin:

Reduces the risk of pregnancy for that
single act of intercourse by 75 percent.

Side-effects: nausea present in 43 percent
of women and vomiting in 16 percent
(ICEC 2004).

Mechanism of action
The precise mechanism of action of ECPs
depends on the time in a women’s menstrual
cycle, when intercourse occurred, and when
the ECPs are taken. ECPs cannot interrupt an
established pregnancy or harm a developing
embryo. According a joint statement issued
by the ICEC and the International Federation of
Gynecology and Obstetrics (FIGO), levonorgestrelonly contraceptive pills prevent pregnancy by
either: 1) inhibiting or delaying an egg from
being released from the ovary when taken before
ovulation; or 2) possibly preventing the sperm
and the egg from meeting by affecting the
cervical mucus or the ability of sperm to bind to
the egg.
Most studies show that levonorgestrel-only ECPs
do not change the histological or biochemical
characteristics of the endometrium, indicating
that they have no mechanism to prevent
implantation (ICEC and FIGO 2008).

“Emergency contraception is not the same
as early medical abortion. EC is effective
only in the first few days following
intercourse before the ovum is released
from the ovary and before the sperm
fertilizes the ovum. Medical abortion is
an option for women in the early stage of
an established pregnancy, but requires a
different drug from levonorgestrel”
(ICEC and FIGO 2008).

ECPs should not be confused with misoprostol,
mifepristone or RU486, which do have an
abortive effect.

Side effects
The main side effects reported include:

Nausea and vomiting are the most
common side effects.

Bleeding disturbances or spotting.
Other possible effects include headaches,
dizziness, fatigue, and breast tenderness.
Most side effects generally disappear within
24 hours of taking the pills. To reduce the effects
of nausea, ECPs can be taken with food, and
anti-emetics can help women who have a history
of nausea or vomiting when taking pills with
hormonal content. If a woman vomits less than
two hours after taking a dose of ECPs, the dose
should be repeated. In cases of severe vomiting,
EC can be administered vaginally (ICEC 2004).

Repeat use
There is no evidence that repeated use of ECPs is
harmful for most women (Abuabara et al. 2004),
apart from the enhanced risk of unintended
pregnancy if ECPs are used routinely instead
of a regular contraceptive method. ECPs are
safe even when used more than once in a cycle
(ICEC 2003b); however, repeated use of ECPs is
not recommended for women who have sexual
intercourse regularly or who may be exposed to
STI/HIV infection. Other contraceptive methods
are more effective at preventing pregnancy as
well as more affordable, and condoms have
the added benefit of protecting against STIs.
If a client reports repeat use of ECPs, the
health provider is advised to counsel her about
switching to a regular contraceptive method.

ECPs and STIs, including HIV
Knowledge of how ECPs work is central to
understanding the crucial difference between
emergency contraception and early medical
abortion. Confusion between the two has
occasionally led to unjustified rejection or
denouncement of ECPs. First, these are different
compounds and categories of drugs. Secondly,
ECPs are effective only in the first 120 hours
after sexual intercourse – before implantation
of the fertilized egg in the uterus begins, which
is when pregnancy begins according to the
medical definition. In contrast, medical abortion
is the termination of early pregnancy through
the dislodging of the implanted, fertilized egg.



ECPs do not protect against STIs, including HIV.
If a woman has been raped, it is important to
give her post-exposure prophylaxis (PEP) for
STIs, within 72 hours of the incident. Routine
prophylaxis for HIV is a matter of considerable
controversy and is not a universally accepted
standard of practice. Health workers should refer
to local protocols dealing with HIV PEP if they
exist (WHO 2003a).

What to do after using ECPs
Providers can use the opportunity of providing
ECP to counsel clients on future safe sexual
behaviors. They should recommend that clients:
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Use a barrier method or abstain from
sexual intercourse until next menses.

Do not use ECPs as a regular
contraceptive method.

Begin using a regular contraceptive
method (see table below).
Providers can also counsel or refer clients for
family planning or other reproductive health
services, especially for rape survivors who
need immediate medical management and
psychosocial care (see section below).

Method

When to start

Condom

Immediately after ECP use - condoms
provide dual protection against
pregnancy and HIV/STIs

Oral

The day after 2nd dose of ECPs, or
within 1-7 days after menses

Injectable
IUD

Within 1-7 days after menses

Implant

The bridging role of ECPs
Bridging to regular contraceptive methods
The moment when ECPs are provided presents
an important opportunity to “bridge” clients
onto a regular and more effective contraceptive
method by communicating information about
other available methods about the importance
of dual protection (including male and female
condoms) and about the correct and consistent
use of contraception. A study in Bangladesh
shows that, after initial use of ECPs (primarily
because of method-use failure), the proportion of
women using a regular method of contraception
increased from 72 to 93 percent (Khan and
Hossain 2008). In India, a follow-up of users six
months after they had used ECPs for the first
time showed that use of a regular family planning
method increased significantly from 67 to 79
percent after using ECPs (Kumar et al. 2007).
Bridging to other reproductive health services
Provision and use of ECPs can also act as a
platform for communicating a range of sexual
and reproductive health messages and services to
clients, including referrals for other reproductive
health services. In Kenya for example, 62 percent
of FP providers gave additional services to their
EC clients even without a formal emphasis
during training on “bridging.” Most often, these
included HIV/STI counseling or referrals for

testing. Notably, nearly half of those counseled
on FP accepted a new or different method, most
often injectables or male condoms (Keesbury,
Owino, and Bradford 2007). Provision of ECP can
also reinforce HIV prevention efforts including
serving as a critical back-up method for HIVpositive women or discordant couples in cases
of method failure, and for those wishing to avoid
the potential of mother-to-child transmission
(Townsend et al. 2007).

Provision of ECPs in different
settings
Emergency contraception is now available
to women in over 140 countries around the
globe, and over the counter in 44 countries
(ICEC 2008). Depending on national laws, it
can be provided through government, NGO
and private clinics, private sector pharmacies
and physicians, community health agents, and
other types of service delivery points. Points
of access vary, depending on the strength of
public health systems and the penetration of
the private market. In South Asia, for example,
EC is provided primarily within well-established
government family planning programs; in Africa,
pharmacies tend to be the most common source
of provision; and in Latin America and the
Caribbean (LAC), it can be found both in public
and private sector outlets.
However, there are very few developing countries
in which ECP could be described as being an
integral and readily available service within the
national RH program. Those where it is readily
available include Argentina, Brazil, Mexico, Peru,
and Bangladesh. In several countries the method
is more widely available, primarily through
the commercial and NGO sectors rather than
the public sector; however, for the majority
of countries it is either not widely available
or available primarily to meet the needs of
women in specific situations, such as post-rape
or university settings. This diversity raises the
possibility of ECPs being associated with use by
particular groups of women with specific needs
only (in Ecuador the public sector provides ECPs
only to rape survivors), and not as a method that
may be of use to the general population following
unprotected sex or method failure. In countries
where there is substantial political or religious
opposition to making ECPs more widely available,
introducing it as a service for particularly
vulnerable women, such as rape survivors, can
serve as the basis for scaling up the service once
introduced.
The primary goal of this handbook is to provide
guidance on programmatic approaches to
mainstreaming ECPs within a national RH



program, so that it becomes as widely available
as other contraceptive methods. ECPs are
frequently introduced into a country for specific
groups of women with a higher unmet need than
the general population. The following section will
review the key lessons about programming ECP
services for use by women with specific needs.
These include young and unmarried women,
survivors of sexual assault, and displaced women
living in refugee camps.
Following this overview of programming for the
needs of women in specific situations, the greater
part of the handbook will review the key strategic
steps that are critical for efforts to mainstream
ECPs to increase their availability for the general
public. Clearly, most countries may need to
mainstream ECP provision to increase access
for the general population while simultaneously
implementing programs that can meet the needs
of women in specific situations. The intention of
producing this handbook is to provide guidance
that can support RH policymakers and program
managers to achieve both goals.
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Addressing the Needs of Specific Populations
Identification of populations with
specific needs

at one point of contact (e.g. the Thuthuzela Rape
Centers in South Africa [UNICEF 2008]).

Unintended pregnancy can place a burden
on any woman, no matter what her situation.
However, there are women in certain situations
who are more vulnerable, both individually and
socially, for whom EC can play an especially
important role in maintaining their physical and
psychological health by preventing an unintended
pregnancy. In this section we review three of the
populations whose needs may be better met by
providing ECPs through specific delivery systems:
survivors of rape, unmarried young women, and
women living in refugee settings.

In several countries (e.g. Ecuador, Guatemala,
Mexico, and Zambia), ECP counseling and services
have been introduced in police precincts and
rape care centers. Experience shows that staff in
these centers require more extensive training in
counseling rape survivors than health staff and
may require special approvals and support from
the health sector. Having this service included in
guidelines and protocols is essential for ensuring
that the staff consistently deliver the services.
When the ECPs themselves are not provided,
these FPCs should refer survivors to pharmacies
or clinics where they can obtain the pills and
be provided written instructions on how to use
them or, if available, to rape care centers where
a broader set of needs can be cared for (Vernon,
Schiavon, and Llaguno 1997; Taracena and
Brambila 2001; Keesbury and Zama 2007).

Rape survivors
Pregnancy resulting from rape is almost always
unintended and traumatic. As a general principle,
ECPs should be made available to all female
survivors of rape who are of reproductive
age or who show signs of secondary sexual
characteristics, who are not pregnant, and who
are not consistently using an effective form of
contraception (WHO 2003a).
A pregnancy test is not required prior to
providing EC after rape, but pregnancy can be
ruled out by using a simple checklist (FHI 2007).
In any case, providers should assure clients that
even if the woman is pregnant, using ECPs will
not harm the fetus. As EC must be administered
within 120 hours of the rape and is most effective
if used as early as possible, any education
messages about post-rape services should
emphasize the critical importance of obtaining
ECPs (and in high HIV prevalence settings, HIV
PEP also) as soon as possible after the rape
(Keesbury, Skibiak and Zama 2006; Keesbury and
Zama 2007; Vernon, Schiavon, and Llaguno 1997).
The narrow window of opportunity to reduce the
risk of a pregnancy after rape requires that ECP
information and services are provided at the first
point of contact (FPC) with a rape survivor, or as
soon as possible afterwards. The first point of
contact varies considerably, but is usually either:
(1) the place where the crime is first reported,
most often at a police station, social services or
public prosecutor offices, legal aid agencies or
women’s refuges; or (2) at the place where the
survivor goes for treatment (either before or
after reporting the crime), such as outpatient
or emergency units at health facilities. Some
countries have, or are developing, specialist
centers that can provide all medical, legal,
psychological, and other support for survivors

Establishing ECP services for rape survivors
at these FPCs may require training providers
as community-based or employer-based
contraceptive distributors under national
guidelines. At a minimum, staff and managers
should be trained on the following:

The characteristics of ECPs
Identifying which rape survivors should
be provided with ECPs

Counseling survivors about their options
and providing ECPs or a referral for them

After provision, referring for STI/HIV PEP
and medical and psychological trauma
management (if not already received)

Depending on the individual’s preference
and the national legal framework,
opening or a referral for opening a
criminal case
Provision of ECPs at the FPC is strongly
recommended over referring to another location
because of the critical need for its immediate use,
especially in situations that lack readily available
transportation (Vernon, Schiavon, and Llaguno
1997; Vernon 1998; Kestler and Ramirez 2004;
Keesbury and Zama 2007).
Female survivors of sexual violence often
sustain physical injuries and after the assault
are more likely than other women to have
unintended pregnancies, report symptoms of
reproductive tract infections, have multiple
partners, and be less likely to use condoms



Providing ECPs at the first point of contact for rape survivors
In Zambia, the majority (91%) of rape survivors in the Copperbelt region go to the police before seeking healthcare
(Keesbury and Zama 2007). Moreover, although 82 percent of all survivors managed to get to a health facility within
the time window for ECPs, only 37 percent actually received ECPs from hospital staff. These results encouraged the
Ministry of Health to train police officers as community-based ECP distributors. Estimates suggest that enabling
police to provide ECPs could benefit up to 59 percent of rape survivors, with little difference between rural and
urban locations (Keesbury, Skibiak, and Zama 2006).
However, the provision of ECPs at FPCs that do not have medically qualified staff may present certain challenges.
In Bangladesh and India, although police stations are a common FPC, police refused to stock or provide ECPs and
only reluctantly agreed to supply information about ECPs to survivors (Khan et al 2008).
Providing brochures on ECPs at the FPC rather than providing the method itself was used in Mexico because in the
absence of official guidelines, staff at public agencies were afraid they could be charged with providing abortions
and providing drugs without a medical license (Vernon, Schiavon and Llaguno 1998). Even when non-medical FPCs
do commit to providing ECPs, compliance with service delivery might vary significantly, and constant monitoring
and supervision of activities is required.

and other contraceptives (IFPP 2004). EC is only
one component of a comprehensive post-rape
care “package” of services necessary to reduce
the range of possible consequences of sexual
violence. As far as is possible, a comprehensive
and integrated care package should be available,
either in a single venue (e.g. the Thuthuzela
model) or, more commonly, through a system of
coordinated referrals among specialized units.

Young women
Young people are defined by WHO as those aged
between 10 and 24 years, thereby including both
adolescents (aged 10-19 years) and youth (aged
15-24 years). For most young people, this is a
time of sexual initiation and experimentation,
often characterized by infrequent, unplanned,
and sometimes non-consensual encounters.
By its very nature, this type of sexual activity
is frequently unprotected or insufficiently
protected against both pregnancy and STIs.
Ensuring access to and use of ECPs can be a
critical component in any RH program’s efforts
to reduce unintended pregnancies among this
population. Young people may thus constitute
an important and growing population to be
reached with ECP services by a national RH
program. Evidence from Kenya suggests that
young people constitute as many as 80 percent
of all public sector ECP clients, and 49 percent of
those purchasing the method from pharmacies
(Keesbury, Owino, and Bradford 2007).
Young people are not a homogeneous population,
even within a particular country setting, and so
ECP programming strategies to reach them need
to be flexible. In most situations, ECP information
and services should be made available through



the same structures and programs as other youth
reproductive health information and services,
such as adolescent-friendly clinics, communitybased programs and, in some settings, schoolbased programs. Because many adolescents
may feel shy, distrust established services, lack
money, and have less knowledge than older
people, it is even more important that ECP
services for young people have the recommended
characteristics of quality contraceptive services in
general, including:

Privacy and confidentiality
Easy accessibility
Reasonably priced services and supplies
Convenient and flexible schedules
Sensitive and approachable staff trained
to counsel adolescents
ECP programming for adolescents through
existing structures requires planning, budgeting,
and undertaking activities that enable the
inclusion of messages and informational
materials within communications strategies,
training of existing staff, and easy delivery
and maintainance of commodity supplies. For
example, within secondary schools, information
about ECPs could be included within a broader
curriculum covering sexual and reproductive
health, or in special ECP-focused sessions that
include this topic could be held for students,
teachers, and parents. In tertiary, and some
secondary education facilities, existing student
health services can be equipped to provide
ECPs, along with counseling and services for
contraception and STI/HIV prevention. For
further information on youth-friendly services
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see Youth Net/FHI (2004), and for resources to
guide ECP programming for young people see
Beitz et al. (2003) and Parker (2005).
Integrating ECP services with related youthfocused activities can also be an effective way to
increase the range and impact of ECP messages,
although a stand-alone project or program on
ECPs for adolescents and youth may not be
acceptable or feasible in many countries.
Further methods of reaching young people with
information about ECPs include:

identifying and using media and
information channels that are accessible
to the youth population. For example,
newspapers, hotlines, youth journals,
websites and advertisements for events
attended by youths.

making ECPs an over-the-counter (OTC)
product available to young people. This
would dramatically reduce medical
barriers in accessing ECPs.

encouraging and training pharmacists to
stock ECPs and to disseminate correct
information to their clients, particularly
youth.

Women living in humanitarian
settings
Relatively little is known about how best to
provide reproductive health services, including
ECPs, in humanitarian settings. Service delivery
to refugees and internally displaced persons
(IDPs) tends to be adapted from models designed
for stable communities, and there is little
information about how these service delivery
models are best used or adapted to the needs
of refugees or IDPs. Moreover, the reproductive
health status and needs of a refugee woman
living long-term in a stable camp setting may be
very different from those of refugees during the
emergency phase of a crisis, or from IDPs and
other war-affected groups (McGinn 2000). This
section reviews some of the issues associated
with programming ECPs in such settings.
Humanitarian emergencies may flare up in a
short time period, and, by their very nature, may
not allow time for intensive and comprehensive
training of providers, which can include medical
and paramedical staff as well as traditional
birth attendants and trained field staff and
volunteers. Ideally, providers should be trained
and sensitized in advance, or, if necessary, by a
dedicated RH advisor after the response begins
(Goodyear and McGinn 1998). Medical staff
should be trained to provide ECP counseling,

Reaching young people with
information about ECPs
A study in Zambia found that pharmacists
and peer educators were the most frequent
sources of information on ECPs for
adolescents, being more widely used than
clinic-based providers and communitybased contraceptive distributors (Skibiak,
Chambeshi-Moyo, and Ahmed 2001).
In Mexico, the IPPF affiliate MEXFAM
introduced ECPs into the curricula of all
reproductive health training courses for
schools and communities and pioneered
ECP services in adolescent-friendly
clinics and in youth peer and community
programs. Awareness of ECPs among youth
significantly increased (Vernon and Durá
2004). Displaying posters, distributing
postcards, and providing telephone hotlines
have also proven effective in informing
youth (Givaudan, Fuertes, and Vernon 1998;
Vernon 1998; Ellertson et al. 2002).
In India, ECPs are now regularly advertised
on many TV channels and FM radio stations
popular among young people. The Ministry
of Health and Family Welfare is establishing
adolescent-friendly sexual and reproductive
health clinics in rural health facilities and
urban district hospitals; counseling on
and provision of ECPs is one of the key
components (MOHFW 2006).
In Kenya, the experience of training
pharmacists in classroom settings was
not satisfactory due to a high turnover of
pharmacists and premature departures
during training. The study concluded that
onsite training and the provision of IEC
materials would be more effective (Beitz et
al. 2003). Another study in Kenya revealed
that pharmacists do not engage their
EC clients in broader discussions about
their health, and therfore lose important
opportunities to discuss STIs and other
relevant RH issues (Keesbury et al.).
In Bolivia, training on-site pharmacy clerks
to provide appropriate and adolescentfriendly information and services through
role-playing with groups of adolescents
substantially increased sales of ECPs
(Arteaga and La Fuente 2001).



STI screening, and prophylactic treatment to
rape survivors, along with necessary trauma
treatment.
Response programs may be required to be
creative when sourcing providers of information
and counseling. In the Kibondo camps of
Tanzania, leaders elected by refugee women
in the camps were trained to do community
education and to counsel rape survivors.
Traditional birth attendants and social services
paraprofessionals were given violence-sensitivity
training, which includes basic information on
ECPs (Goodyear and McGinn 1998).
ECPs should be available right from the beginning
of a response to a humanitarian crisis. WHO’s
Inter-Agency Working Group for Reproductive
Health in Refugee Situations (WHO 2003b) has
developed a Minimum Initial Service Package
(MISP) to address the reproductive health needs
of displaced women and girls, which includes ECP
as one of the services to be provided. WHO has
also included ECPs in the “New Emergency Health
Kit,” a package of basic commodities delivered
immediately to every newly identified emergency
site. Program staff working in emergency settings
should be aware of the need to source, order, and
distribute ECPs early in the emergency, tasks that
may be neglected in the hectic first days.
The key barriers to providing ECPs in
humanitarian settings are similar to those in
the general population – women’s (and health
providers’) lack of knowledge about ECPs,
stigmatization of users, inadequate supplies,
and provider insensitivity or bias. As in the
general population, these barriers lead to underutilization. Data from refugee camps in seven
countries show that 54 percent of female rape
survivors did not receive ECPs within 120 hours
of an incident in 2007 (UNHCR 2008). With this in
mind, it is important to consider that to ensure
compliance, one-dose dedicated ECPs may be
more appropriate for transient clients.
Limited understanding and knowledge of
ECPs in refugee camps often mirrors that of
the pre-crisis population. A study in Kakuma
camp in Kenya found that, as in the general
population, ECPs were widely perceived to be
abortifacients. Moreover, of the 34 percent
of women and 27 percent of men who were
aware of rape cases, only 11 percent knew that
emergency contraception was available through
the camp health services, demonstrating the
need for greater information to be disseminated
among refugee populations (Muia, Fikree, and
Olenja 2000). After providing training on EC
to professional service providers, women’s
support group leaders, community health
leaders, community health workers, and family



Health kits for emergency situations:
procurement details
UNFPA. 2001. The Reproductive Health Kit for
Emergency Situations, 2nd Edition.
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Tel: +1212 2975398
Fax: +1 212 2974916.
World Health Organization. 1998. The New
Emergency Health Kit 98
Order from: IDA Foundation, P.O. Box 37098, 1030
AB Amsterdam, The Netherlands.
Tel: +31 20 4033051
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World Health Organization. 2001. Clinical
management of survivors of rape: A guide to the
development of protocols in refugee and internally
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whqlibdoc.who.int/hq/2002/WHO_RHR_02.08.pdf

planning promoters in Kakuma, knowledge about
the method more than doubled in the refugee
population, from 15 to 35 percent (Muia et al.
2002).
A humanitarian response team may need to
consider national laws and protocols in advance,
and take timely steps to advocate for change, if
appropriate. For example, NGOs in Sudan say that
they do not advertise services for rape survivors
because Sudanese law (Article 48) prevents
doctors from treating rape survivors without a
referral from the police department. Doctors and
health personnel can be arrested for violating this
law and some have been threatened, to prevent
them from providing services. In Kakuma camp
in Kenya, despite trained providers increased
knowledge about EC among refugees, EC services
could not be institutionalized and contraceptive
services continued being provided as they had
been before the training (Muia et al. 2002).
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Introducing and Mainstreaming ECPs
Step 1.
Registration of a dedicated ECP
product
In all countries, medical drugs and products
need to be registered and to comply with
national requirements before they can be made
available to the population through public or
private channels. The overall purpose of these
regulatory requirements is to ensure the safety,
efficacy, and quality of all medicines provided to
the public. If a product is not registered (usually
determined through a review of policy documents
and/or interviews with key informants), then the
process of registration explained below needs to
be followed. If ECPs are already registered in the
country, then proceed to Step 2, introduction of
ECPs.
The process of product registration usually
involves the following steps:
a.
b.
c.

Identify partners to register the ECP
product(s).
Conduct a pre-registration assessment, if
appropriate.
Select partners and conduct advocacy with
relevant authority.

Identify partners to register the ECP product(s)
The registration of pharmaceutical products
can be a complex and lengthy process involving
different steps and requirements. For this reason,
in most countries reproductive health program
managers have relied on product manufacturers
and/or local distributors of pharmaceutical
products to conduct the actual registration
process and submit the required applications and
documents. This also has the advantage that by
involving the commercial sector, the distribution
of ECP in pharmacies and other commercial
outlets is achieved. Experience has shown that
a local non-governmental partner is usually
needed to undertake the registration process; the
government agency in charge of medical product
registration should be consulted for guidance in
the procedures necessary for product registration
in the country.
The most commonly required information for
registering ECPs includes product information,
manufacturing process, packaging requirements,
clinical research results, product quality tests,
and other product-specific information (PATH
2004). The active compound in ECPs is found in
other contraceptives available in most countries
and therefore governmental regulatory agencies

Regimen advice
It is important to ensure that, at the time
of applying for registration, the latest
available information on the drug is used.
For example, WHO has currently approved
one dose of ECP containing 1.5mg
levonorgestrel. It is therefore advisable
to register the 1.5mg levonorgestrel
regimen first, as registering it after
obtaining approval of the two-dose 0.75mg
levonorgestrel regimen would require the
whole process to be repeated.

can usually facilitate the registration of ECPs.
Technical information on the product should
be provided by the product’s manufacturer in a
confidential dossier that is submitted directly to
the regulatory agency.
Conduct a pre-registration assessment, if
appropriate
A test or assessment may or may not be a
precondition of product registration. If it is
required, it is necessary to determine:

the organization responsible for
conducting the test (government
institution or NGO).

the type of test (for example, a
biomedical or field test).

who is responsible for utilizing the
findings after the results are available.

Field testing for registration
In Ethiopia, the national Drug Administration
Control Authority requires that new drugs
be “field tested” prior to registration. For the
MOH to introduce ECPs into their method
mix, it was necessary to conduct in-country
research. Instead of repeating the existing
and universally-accepted clinical trials, the
MOH undertook an operations research
study. This effort demonstrated both the
feasibility of providing ECPs in government
facilities and its acceptability among clients.
Combined with global clinical data, this
evidence provided the basis for successful
registration of the country’s first-ever
dedicated ECPs in 2006 (Keesbury, Aytenfisu,
and Bradford 2007).



Even if a pre-introduction assessment is not
required by the government, the evidence
provided by such an assessment can be used in
subsequent advocacy campaigns to register and
incorporate ECPs into the national reproductive
health program, as well as help to counter the
potential opposition posed by political and
religious groups.
In some cases, the national RH program or an
NGO can facilitate the registration process by
conducting feasibility studies, market research,
and/or “willingness to pay” surveys (which
document the need, market, acceptability, and
price of the product) and by raising the interest
of manufacturers and distributors, including RH
program and regulatory agency managers.
Select partners and conduct advocacy with
relevant authorities
Changing policies and influencing programmatic
decisions can better be achieved if a large
number of agencies advocate for the change. If
possible, partners with credibility such as RH
service delivery organizations, feminist and legal
aid organizations, MOH managers and donor
organizations should be engaged in advocating
for the introduction of ECPs with the relevant
authority. Advocacy serves to sensitize political
leadership, raise public awareness, and can
potentially minimize the risk of community
objections.

Step 2.
Introduction of ECPs into the public
sector and NGOs
In most countries, the step of registering
a product is conducted by pharmaceutical
companies and distributors; therefore, the
placement of ECPs in private sector pharmacies
usually follows shortly after registration of the
product. By contrast, the introduction of the
product into large public sector and NGO service
delivery organizations usually requires extensive
advocacy and technical assistance. In most Latin
American countries, and in Bangladesh, India,
Nepal and Pakistan, for example, ECPs were
registered and available in the private sector
for several years before their introduction into
public-sector programs. Experiences from several
countries show that the process of introducing
ECPs into public and/or NGO sectors varies
significantly and so the following guidelines
serve primarily to serve as a checklist of issues
to consider when planning the introductory
process. Moreover, government engagement and
ownership of the process is essential for creating
an enabling policy environment. Doing so often
requires development partners to financially
support the introductory process, broadening the
base of national stakeholders and/or developing
a formal national strategy that the government
can endorse. The introductory step can include
the following four activities:

Conduct a diagnostic assessment for the
introduction/reintroduction of ECPs.

Introducing ECPs through the
Yuzpe regimen
It is possible to introduce ECPs in
countries without registered dedicated
products by using the Yuzpe regimen,
which involves provision of combined
OCPs that are already registered for
contraceptive use in most countries
worldwide. In some Latin American
countries, initial advocacy efforts included
national and international seminars and
workshops to present the Yuzpe method
and generate buy-in from relevant actors,
including policy makers and NGOs. As
a consequence, the Yuzpe regimen was
included in the official family planning
service delivery guidelines in Brazil,
and other countries, before dedicated
products were available (Vernon 1998;
Diaz et al. 2007).
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Partner with stakeholders and
conduct evidence-based advocacy with
policymakers.

If required, conduct operations research,
feasibility and/or acceptability studies.

Include ECPs in FP guidelines and other
policy documents and plan for its phased
introduction.
Conduct a diagnostic assessment for the
introduction/reintroduction of ECPs
Diagnostic assessments are a critical preintroduction stage and should include multisector consultations and dialogue to identify
potential challenges and sources of resistance
to ECP products and services. As a multi-party
exercise, strategic assessments contribute
towards generating knowledge, supporting
consensus among country participants,
and extending decision-making beyond the
government. The assessment should include
stakeholder and expert consultations, as well as
qualitative and quantitative surveys to evaluate
the perspective of decision makers, providers,
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and users. Sources of information for the
assessment can include, among others, DHS
surveys and other national and international
research, policy documents, key informers in
service delivery, policy, women’s health advocacy,
and legal aid organizations. The assessment
should:

Help programs to understand the
existing family planning policies and
organization of services, to make
recommendations on where ECPs could
be offered, who could offer it, how to
identify and train providers, which IEC
materials would be needed, and how to
include ECPs in commodity procurement
and distribution processes, and within
the management information system.
The assessment should also determine if
any policies would need to be updated,
as well as the process for changing these
policies, and how best to incorporate
ECPs into the national FP service delivery
guidelines.

Provide data to support the case for
why ECPs would be useful within this
population by describing current national
levels of unprotected sex, proportions
of unintended pregnancies, incidence of

unsafe and safe abortions, incidence of
rape, and method failure rates, among
others.

Identify specific populations that could
benefit from the introduction of ECPs
and the feasibility of reaching these
populations through various service
delivery systems. As with most national
RH programs, vulnerable sectors of the
population, such as young women, the
urban poor, and displaced and refugee
populations, are harder to reach.

Collect information to help understand
the cultural context and sensibilities
around ECPs, which groups could
potentially oppose its introduction as
well as which reasons they may use and
the types of messages that could be used
to properly inform decision-makers.

Identify the most relevant stakeholders
who could partner with programs in
advocacy efforts and who should be
provided information on ECPs. In several
countries these have included not only
reproductive health service delivery
organizations, but also women’s health
organizations, members of the legislative
and judicial powers, and the media.

Using evidence to demonstrate ECP acceptability
In Bangladesh, research demonstrated that 33 percent of pregnancies were unintended due to method
failure or unprotected sex. Many of these pregnancies resulted in abortions performed in unsafe conditions
leading to possible complications or death. Unprotected intercourse is common and frequent. These facts
supported the introduction of ECP into the national program as a backup method for existing family planning
methods (Khan and Hossain 2004).
In Ghana, the national IPPF affiliate facilitated the introduction of ECPs into the public sector by undertaking
a pilot to demonstrate user acceptability of ECPs, training providers, initiating demand creation activities,
supporting the registration of a dedicated product, and ensuring its availability by procuring and distributing
it to providers in both the private and public sector (Osei 2007).
In Mexico, the introduction of ECPs into the public sector needed intensive advocacy efforts for almost
a decade and required an external review of scientific evidence to prove that ECPs are not abortifacients.
Support from feminist groups and other NGOs, as well as from individual MOH officials, were also factors
that led to its introduction (Lara et al. 2007).
The Government of Nepal relied on IEC materials developed in Bangladesh and India and on technical
assistance from the Population Council and a national research institution, the Nepal Fertility Care Centre,
to introduce ECPs in a phased manner (Sherestha, Khan, and Hossain 2008).
In Pakistan, program managers were concerned about a possible backlash from conservative Muslims
when introducing ECPs. Consequently, introduction of the method began only after a study tour by key
stakeholders to Bangladesh, another country with a predominantly conservative Muslim population, to
observe how it was provided and to gauge the population’s response to its introduction (Khan et al. 2008a).
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Partner with stakeholders and conduct
evidence-based advocacy with policymakers

If required, conduct operations research,
feasibility and/or acceptability studies

NGOs and research institutions across the
world have played an important role in
encouraging governments to introduce ECPs
into their reproductive health services. They
have done this by providing policymakers
with scientific information that presents a
rationale for the introduction of EC and by
sharing experiences of other programs. NGOs
also typically play a critical role in ensuring
EC supplies during introductory pilot projects,
convening stakeholders, developing training
curricula and providing training, facilitating
guidelines on ECPs, and conducting diagnostic
assessments. The likelihood of introducing and
mainstreaming ECPs in the public sector is higher
when done in partnership with organizations
that have influence within government bodies,
enjoy credibility for being honest, and maintain
scientific rigor in their work. In the absence of
substantial public sector involvement, ECPs may
become the sole responsibility of NGOs or the
private sector. As the former usually have limited
coverage and the latter responds to market
forces, this may mean that ECPs will not be
available nationally and/or for those with specific
needs, as is the case in Nigeria (Apsel 2007).

In several countries in Asia, Africa and LAC,
diagnostic, social science, and operations
research have been undertaken to provide
policymakers with evidence regarding the
feasibility and acceptability of ECPs. Without
this evidence, it would not have been possible to
revise existing policies, design an introductory
strategy, or ensure that introduction of ECPs will
not lead to controversies or backlash. When the
results of feasibility studies, operations research,
and program experiences from neighboring
countries are convincing and credible, there may
be no need to conduct additional studies.
Include ECPs in FP guidelines and other policy
documents and plan for its phased introduction
The inclusion of ECPs into service delivery
guidelines is an important aspect of the
introduction process, especially if the method is
to be mainstreamed. This process may involve
a period of advocacy, technical assistance,
and strategic planning by stakeholders and
reproductive health experts. In some countries,
such as Mexico, new contraceptives cannot be
introduced into public sector programs until

Using evidence to increase ECP availability
In Bangladesh, policymakers questioned the social acceptability of the method and needed to understand
the operational changes needed for introducing ECPs into the public health system. A formative study
followed by operations research showed that women would use the ECPs if they were made available, that it
was feasible to introduce ECPs into the government’s program, and that paramedics as well as community
workers could provide ECPs. These results facilitated the required policy change and the introduction of ECPs
into the National Family Planning Program (Khan and Hossain 2004).
In India, ECPs were initially available only by medical prescription, which limited their use. The medical
profession opposed making ECPs an over-the-counter (OTC) drug, which prevented paramedics from
providing them. Policymakers requested research to show that paramedics and public extension workers
could provide services of a similar quality to physicians. The study results supported this, and policymakers
were willing to change national policy to make ECPs available over-the-counter (Kumar et al. 2007).
In Latin America, seven countries approved ECPs after MOH and NGO program managers attended a
conference to review the results of operations research projects in other countries as well as other scientific
evidence. They also received technical assistance to adapt the method in their service delivery guidelines and
systems (Vernon 1998).
Despite nearly a decade of public sector provision, ECP use in Kenyan clinics and hospitals remained
limited. To assist the MOH in meeting its dual goals of ensuring ECP access for adolescents and sexual
assault survivors, the Population Council conducted a national assessment of public sector providers and
facilities. It found that ECP services were biased toward sexual assault survivors and that the majority of
providers were not sufficiently trained to offer ECPs in the context of family planning. In response, the MOH
launched efforts to strengthen pre-service training on ECPs in medical and nursing schools, and to deliver
contraceptive technology updates to in-service providers (Keesbury, Owino, and Bradford 2007).
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they have been included in the national service
delivery guidelines, and the changes have been
made official by publication in the official
gazette. (In the private sector, however, standard
drug registration regulations apply.) As has been
the situation in Bangladesh and Kenya, if staff
from the organization leading the introductory
activities can work closely with the government
(such as serving on its technical committees),
opportunities arise for making changes to the
guidelines and teaching curricula.

Step 3.
Training and building the capacity
of ECP providers
Training service providers is a vital component
for introducing and mainstreaming ECP services.
In many contexts, particularly in larger countries,
training can be costly and logistically challenging.
The following section suggests various training
strategies that can be adopted according to
need and context, which will help to build the
overall capacity of the RH system to organize and
monitor training for introducing ECPs.

Who should be trained
What information a provider needs to
know

Strategies for training service providers
Strategies for mainstreaming training in
ECPs

Content of typical stand-alone
training session
First session: Overview of the demographic
and reproductive health situation and
discussion of the role of EC as a reproductive
health intervention.
Second session: Definition of EC, and
discussion of when and how ECPs should be
taken.
Third session: Service delivery guidelines on
how to provide ECPs, according to client’s
particular needs.
Fourth session: Counseling on ECPs,
monitoring and logistics management, and
frequently asked questions.
Example from Bangladesh (Khan and Hossain 2008)

populations. In both the public and private
sectors, the following have been instrumental in
providing EC information and services to women
(PATH 2004):

Nursing and midwifery staff
Physicians
Paramedics
Trained community health workers
Adolescent peer educators

Who should be trained
Providers of ECPs will differ in each country,
depending on the whether they are being
introduced through the public or private sectors,
through clinics, pharmacies, outreach workers,
or non-medical staff, as well as the regulations,
cultural context, and preferences of key target

Private sector pharmacists and pharmacy
counter staff

Gender-based violence (GBV)/rape
survivor counselors and legal assistance

Police and forensic medical personnel

Stand-alone training
In Zambia, stand-alone training was used to provide police officers with the skills to deliver ECPs
to sexual assault survivors. As non-medical personnel, their training required more time than
health care providers. This training was conducted through a five-day course that followed a
condensed version the MOH’s curriculum for community/employer-based distributors. It focused
on the essentials of reproductive physiology, contraceptive technologies, sexual assault response,
integration with other services, and client/survivor counseling (Keesbury, Aytenfisu, and Bradford
2007).
In Bangladesh, stand-alone training was used when training the entire cadre of family planning
providers (more than 45,000 providers). Senior program managers and district level officials were
also oriented on ECPs before training of trainers and service providers. Initially, a group of master
trainers was developed to train a large number of trainers, and the stand-alone training was then
rolled out using a cascaded approach (see opposite page) (Khan and Hossain 2008).
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What information a provider needs to know
A training curriculum should include essential
information about ECPs, an update of other
contraceptive methods, related reproductive
health issues such as STIs/HIV, and counseling
on the importance of bridging to regular
contraception and provision/referral for services
(PATH 2004). Clinic and community health
providers should also be trained to include
ECPs in all FP counseling sessions and health
education activities. The content, focus, and
range of information communicated during
the training will vary according to the type of
provider. For instance, FP staff may require
additional information on bridging to further
FP and STI services, while pharmacists may
benefit from advice on providing a confidential
service. Capacity-building can start even before
the registration of a dedicated ECP product, as
combined OCPs are available in most countries
and can be used for the Yuzpe regimen prior to
the introduction of a dedicated ECP product.
Strategies for training service providers

Stand-alone/targeted training. Training
specifically on ECPs is an effective means
of building the capacity of specific
groups of providers so that they have a
comprehensive understanding of ECPs.
This type of training can usually be done
in a short period of time in a classroom
setting for those providers who already
have a basic understanding of and
competency in providing FP services.
Unfortunately, it can prove expensive,
as it needs a distinct budget and may
not be the best option for providers who
cannot easily leave their place of work.
This strategy may not be appropriate for
scaling up the ECP program throughout a
national public health system unless the
required funds are available.

Innovative training materials
In Venezuela, ProSalud InterAmericana, a national
NGO, has created an interactive CD that is
distributed cost-free to service providers for their
self-training on ECPs. The disc has been used by
NGOs and MOHs in several countries in the region
(Martin 2004). For a demo of the CD, see http://
www.prosaludinteramericana.org/esp/cd/demo.
html.
The Central Board of Health in Zambia, with NGO
partners, developed a self-directed training manual
on “Family Planning in Reproductive Health,”
which included a module on ECPs and counseling.
Testing the approach demonstrated that it was as
comprehensive as classroom training, although
providers required 10-15 weeks to complete the
course at their own pace (Keesbury 2007).

Integrated training. Training on ECPs
can be integrated with other training
opportunities, such as contraceptive
technology updates or other training
on RH issues. This strategy can be
more cost-effective than stand-alone
training and can reach a large numbers
of trainees, but it is important to ensure
that the depth and quality of the training
are not compromised. The major limiting
factor is that it can only be used if other
training opportunities exist that are
timely and for the appropriate type of
providers.

Self-directed training. Self-directed
training is a tool that is used for
distance education provided either
completely or partly outside of a central
facility. It requires supervisory support,

Integrated training
In India, the MOH adopted an integrated approach to train 200,000 health workers on ECPs because
of the prohibitive cost of organizing stand-alone training. ECP training was integrated into the
Reproductive and Child Health training program under which paramedics undergo three days of
training. All paramedics were then reoriented in the new service, through a two-hour session on
ECPs. Subsequently, ECPs have been included in the MOH Contraceptive Technology Update (CTU)
manual.
The integrated training methodology has also been successfully adopted in Guatemala, El
Salvador, and Kenya. In Kenya, ECP services were strengthened as a component of regular
national CTU trainings provided by the Ministry of Health. This strategy ensured that ECPs were
considered an essential component of routine family planning and reproductive health services and
not as an additional burden on service providers.
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but may prove an effective option
in circumstances where there are
inadequate resources for stand-alone or
integrated training, or where providers
are unable to leave their work stations.
Strategies for mainstreaming training in ECPs
All three training strategies described above
are suitable when introducing ECPs, and can
be developed, tested, and revised through
introductory pilot-testing. Once ECPs have
been successfully introduced into the national
program, which is usually on a small scale, a
different training strategy is usually needed
to mainstream ECPs throughout a national RH
system. Three approaches can be recommended:

In-service cascaded training. Cascaded
training can be a cost-effective means
to reach large numbers of providers
with in-service training. It can be used
with either a stand-alone or integrated
training curriculum, depending on
whether there are funds available for
supporting an ECP-specific training
program (as was the case in Bangladesh,
with funding provided by the
Government, UNFPA, and USAID). There
may also be regular training programs
(for example, CTUs and the RCH program
in India) into which ECP training can be
integrated.
When designing a cascaded training
strategy for a large-scale public program,
it is advisable to develop a cadre of
Master Trainers who can then train
the trainers themselves. The Master
Trainers and trainers are then available
to build the capacity of service providers
throughout the system. In Bangladesh, a
total of 300 Master Trainers and 2,300
trainers were used to build the skills
of 45,000 service providers (Khan and
Hossain 2008). The cascaded training
strategy is dependent on the funding
available, the motivation and availability
of all groups of trainers, and a consistent
level of supervisory support to ensure
that the training at all levels is of
acceptable quality and occurs as planned.

Steps for cascaded training
in the public sector in Bangladesh
 Train a group of Master Trainers, who then…
 Train a group of trainers, who then…
 Train the service providers

Integrating ECPs
into pre-service training
In Kenya, ECP advocates assisted in the
review of the family planning curriculum
of the National Medical Training College,
providing the resources and technical
expertise needed to strengthen instruction
on ECPs. To support this new emphasis, the
Population Council is providing a refresher
course on EC for tutors nationwide.
In Bangladesh, a chapter on ECPs has been
incorporated in the national contraceptive
manual, which is the reference book for
all paramedics and medical professionals
working in the family planning sector.
Similarly, in India, ECPs have been
incorporated in all MOHFW training
manuals, such as contraceptive technology
updates and a handbook for introducing
adolescent-friendly clinics for reproductive
and sexual health.

Pre-service training in EC by training
institutions. The most cost-effective
way to mainstream ECPs, certainly over
the long-term, is to integrate them into
pre-service training for personnel who
will likely provide them as part of their
work. The incorporation of ECPs into
the curricula and training manuals of
medical training institutions (such as
medical schools, pharmacy schools,
nursing schools, and paramedic training
courses) is critical to institutionalize ECP
training and secure its sustainability in
the health system. This approach will
also ensure that ECP training is provided
to medical professionals working in both
the public and private sectors.

Quality assurance and refresher
training. Follow-up training is an
important aspect of ongoing quality
assurance. Refresher training, which
can be done during routine supervisory,
monitoring, and/or quality assurance
visits by supervisors, should review
and emphasize the key elements of
delivering ECPs, as well as update
providers on any recent developments
and amendments to service delivery
guidelines. Particular attention should
be paid to ensure that providers are not
letting personal biases prevent them
from offering information and providing
appropriate counseling, that they are
emphasizing the need for bridging to
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regular contraception, and that they are
screening for other RH needs, especially
for STI/HIV management. For example,
in Bangladesh, all supervisors have been
instructed to ask questions about ECP
services during visits and to conduct a
15-minute discussion during monthly
staff meetings. Provision of ECPs is now
included in the ministry’s MIS system.

Step 4.
Making the case for and raising
public awareness of ECPs
Raising public awareness about EC is a critical
introductory step to ensure that the target
populations, general and specific, are aware
of the method, know how it works, and know
where to obtain ECPs. Key messages and means
of communication are described here for further
detail and guidance (see box on opposite page).
Experience has shown that the following
components will usually be necessary in any
efforts to ensure that the potential users are fully
aware of ECPs, that possible opponents can be
educated on the benefits of ECPs, and that a case
can be made for including ECPs in the national
RH program.

Understand the social, cultural, religious,
and legal context.

Select communication channels based on
their audiences.

Use the media to reach specific
audiences.

Develop the key messages.
Understand the social, cultural, religious, and
legal context
The legal regulations in the country about where
and how ECPs may be promoted need to be
well understood. Many countries do not allow
messages on contraception in the media or
restrict the content and schedule of messages.
For example, many Muslim countries prohibit
advertising of family planning methods in general
or of the condom in particular. It is also essential
to understand the social, religious, cultural, and
political environment of the country to avoid
creating unnecessary controversies.
ECPs are relatively easier to introduce and
mainstream in settings with higher levels of
contraceptive knowledge and use. When a large
proportion of couples are already protected by
reliable contraceptive methods, however, the
potential impact of a successfully introducing
ECPs can seem marginal to decisionmakers. In
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Resources for outreach on ECPs
Pathfinder:

 Emergency Contraceptive Pills, 2nd edition.
http://www.pathfind.org/site/DocServer/
ECP2ed_for_web.pdf?docID=10203
PATH:
 Resources for emergency contraceptive pill
programming: a toolkit
www.path.org/files/RH_ec_toolkit.pdf
International Consortium for Emergency Contraception:
 Adapting Resource Materials for Local Use.
www.cecinfo.org/files/Adapting-materials.rtf
 Materials for EC Advocacy – Questions and
Answers for Decision Makers
www.cecinfo.org/files/QA-for-Decision-Makers.rtf
 Materials for EC Clients
www.cecinfo.org/files/Sample-Mtrls-for-Clients.rtf

such cases, the rationale for introducing ECPs
into a country should be framed in terms of
meeting the needs of couples who experience
method failure as well its role in post-rape
care. In Bangladesh, where 60 percent of the
population uses contraception, one-third of
pregnancies are unintended and usually occur
due to method failure. Similar arguments have
worked well in Nepal and Pakistan.
Knowledge and awareness about ECPs among
both providers and potential clients in all regions
of the world is still quite low. Consequently,
mass media campaigns to rapidly increase
awareness and correct knowledge of ECPs at the
population level can significantly and quickly
increase the use of ECPs. The success of mass
media campaigns, as seen in India, Kenya,
and various countries of Latin America, was
demonstrated in the sharp increase in ECPs sales
in urban areas after advertising started. Short
periods of widespread exposure to the correct
information can be as effective as long-lasting
media campaigns that target specific and/or
geographically limited populations.
Select communication channels based on their
audiences
The two primary audiences for mass media
campaigns are potential users of ECPs and those
who can advocate and provide information,
counseling, and services. An assessment
of the mass media available in the country,
including their policies on the advertisement
of contraceptive products and the types of
audiences they reach, is essential before deciding
to use this channel.
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Strategies for engaging the mass media
ECafrique has worked extensively with media partners to transform the public discourse on EC. In conjunction
with a Kenyan media group, it prepared a “rapid response” kit to help journalists and NGOs respond to incorrect
media reports and to inform articles supportive of EC and supported a four-day skills-building workshop for 22
leading health reporters from East and Southern Africa. The workshop led to over 50 stories on EC and other RH
issues featured in print, radio, television, and the vernacular media (ECafrique 2006).
In Mexico, a press kit was sent to mass media organizations that covered health issues. Subsequently, more
than 21 articles were published in national magazines and newspapers, six notes given on radio programs, and
one mention in a national news program; ECPs were also included in the plot of a soap opera. It was estimated
that this simple resource helped to reach 11.8 million persons, at a total cost of less than $US 1,000 (Givaudan,
Fuertes, and Vernon 1998).
Likewise, in India and Bangladesh the media played a positive role by publishing articles highlighting and
supporting the need to introduce ECPs into the national reproductive health program. Extensive media coverage
in India, which followed an advocacy project supported by the Packard Foundation, played a pivotal role in the
subsequent approval of ECPs (Khan and Hossain 2008).
The press in Argentina covered the announcement of free government provision of ECPs and supported its
introduction in university health services. Newspapers also denounced legal challenges, arguing that the new
policy affected the most vulnerable who could not afford to buy ECPs from a pharmacy (La Nación 2007).
The media have also been very actively involved in the public debate over public provision in Chile, adopting
positions for, against, and neutral to EC (La Nación 2006; La Nación 2007; La Nación 2008; Faúndes et al. 2007).

It is possible to reach different audiences and
communicate different messages depending
on the media used (print, radio, television, or a
combination). Such an assessment can be made
by considering the following media outlets and
opportunities available:

Newspapers, magazines, radio stations,
and television channels publish
information on contraceptive methods,
reproductive health, gender, and
women’s empowerment. In Bangladesh,
for example, journalists received
information about ECPs and wrote
articles during the pre-introduction
period. In India, pharmaceutical
companies used TV advertisements to
make the public aware of ECPs.

Publicity and communications agencies
can help to determine the channels,
timing, frequency, and the duration
of a planned campaign. They can also
help develop and deliver the campaign
messages. In some countries, such as
Mexico, these firms have agreed to work
on a pro-bono basis. In others, such
as Kenya, Ghana and Ethiopia, social
marketing firms have launched media
campaigns intended to increase sales
primarily in the private sector.

Producers and scriptwriters of soap
operas and other entertainment

programs could integrate EC into
their storylines. In Mexico, a press kit
on ECPs was sent to various media
companies with suggestions on how to
use the material based on examples from
different countries. The script writers of
one of the most popular soap operas at
the time (Mirada de Mujer [A Woman’s
Glance]) introduced ECPs into the plot
of the program, following the lead of a
similar incorporation in ER, the popular
medical series in the US.

Community-based channels – such as
community radios, community theatres,
and youth groups – could potentially
include ECPs in ongoing activities.

Health and family planning telephone
and internet hotlines can provide
information on ECPs. In Kenya,
counselors working at an HIV/RH
information hotline have been trained to
answer questions on ECPs and provide
referrals to other methods or services,
such as VCT or post-rape care. In
Bangladesh, pharmaceutical companies
used hotlines to provide answers about
their ECP products and how to use them.

Mass mailings: brochures, scientific
articles, posters, and other printed
materials can be sent to target audiences
such as private physicians, pharmacists,
women’s health organizations, schools

17

and universities, factories and assembly
plants, and rape survivor care centers,
among others. In Mexico, this strategy
proved to be effective in increasing
knowledge of ECPs among these groups.
Further, it has been found that those who
receive the IEC materials are likely to
use them and to inform and train others
(Givaudan, Fuertes, and Vernon 1997;
Vernon and Llaguno 2001; Martin 2004).
Use the media to reach specific audiences
In Paraguay, through an alliance with PSI, the
local IPPF affiliate Promesa conducted social
marketing of Pronta®, a dedicated progestinonly ECP product. At the beginning, extensive
formative research was undertaken to develop
the brand and marketing strategy; subsequent
marketing efforts have primarily targeted
service providers and youth. Promesa and PSI
created an interactive CD of training materials
for providers. Promesa also communicated
with youth through a weekly radio program,
a network of peer-educators/promoters, and
other outreach facilitated by the internet and cell
phone text messaging. Married women and men
were also reached by integrating ECP messages in
general, as well as information about Pronta® in
particular, into Promesa’s sexual health activities
(Martin 2004).
In the absence of a commercial advertising
campaign, marked increases in awareness can
and have happened when national debates
spontaneously generate mass media coverage,
especially when such exposure is achieved
through coordinated public communications
strategies. This has happened in Argentina, Chile,
Colombia, and Mexico (La Nación 2007; La Nación
2008).
In some countries, media coverage has been
obtained through carefully planned public
relations strategies, including several components
such as press conferences, press releases, and

widely distributed media kits. In other settings,
media attention has been achieved through paid
airtime by large-scale social or social-commercial
marketing campaigns, as was the case of PSI’s
promotion of Postinor in Venezuela (ICEC 2005).
Develop the key messages
Different messages need to be considered for
each of these audiences when raising awareness
about ECPs. The emphasis of the messages will
vary depending on the audience, but all messages
should have correct, science-based information.

For potential users and providers. It
is important that they know which ECP
options are available, how and when
ECPs can be used, dosage and schedule,
sources of supply, mechanisms of action,
possible side effects and management,
and the need to bridge to a regular
effective method.

For those who oppose ECPs. It is
important to communicate ECPs’ mode of
action (i.e. that it is not an abortifacient),
that its use does not lead to increased
sexual activity or risky behaviors, and
that it has a bridging role in encouraging
regular use of more reliable contraceptive
methods.
The following steps may help in the development
of effective messages for both groups:

Identify existing IEC materials on ECPs
that could be adapted and used in
educational campaigns.

Pre-test the messages for clarity, cultural
sensitivity, and appropriateness, and
ensure that they appropriately address
the information needs of potential users,
providers, and opponents.

Give only one to three messages at a
time.

Reacting to negative media
In Kenya and Botswana, media reports have suggested that increasing access to EC through
pharmacies encourages adolescents to “eat ECPs like chocolates” (Okwemba and Anyona 2004). These
reports, largely based on anecdotal evidence from a small number of pharmacists, have significantly
threatened provision of ECPs in both countries. Reacting to these articles, policymakers became
concerned that increasing availability of ECPs may encourage risky sexual behaviors in the context of
high HIV prevalence. Advocates in both countries successfully lobbied against sustaining restrictions
to access through personal communication and both governments are now working with ECafrique to
develop strategies for ensuring responsible ECP provision in the private and public sector outlets.

18

Introducing and Mainstreaming the Provision of Emergency Contraceptive Pills in Developing Countries

Step 5.
Mainstreaming: Scale up and
sustainable institutionalization of
ECP services
Introduction of ECPs into a national RH program
is usually undertaken as a pilot project; once its
provision is proven to be feasible, the challenges
are (1) mainstreaming delivery of ECPs by
taking to national scale those practices that
were demonstrated to be feasible and effective
during the pilot phase, and (2) ensuring that
they can be sustained on a routine basis so that
ECPs become a standardized method within the
range of services made available. Anticipating
and planning for scale-up and sustainability
should be included at the outset of planning;
if not, the activities proposed may not be
replicable at a larger scale or sustainable over
time. This is a critical issue and particularly
relevant for the introduction of ECPs, given the
sensitivities concerning the method, even after it
has been proven socially acceptable and feasible
to provide. In Zambia, for example, despite
the success of pilot efforts and subsequent
introduction into national FP guidelines, ECPs
remain unavailable in the public sector due to
limited funds for contraceptive procurement.
Similar barriers have been seen in Ghana,
Ethiopia, and Nigeria, where the achievements of
introductory efforts flagged at the mainstreaming
phase (Muteshi and Keesbury 2007).
There is no simple formula or framework for
mainstreaming ECPs that could be described here,
as each situation will determine how a successful
pilot could best be scaled up. Key lessons drawn
from a range of experiences with mainstreaming
ECPs provide guidance on issues that should be
considered, even before starting a pilot project.
1. Scaling up the delivery of ECPs should
be one of the objectives when pilottesting its introduction. At the time of
designing the introduction, the intention
should always be that, whatever model is
developed for delivering ECPs on a small
scale, it should also be appropriate for
delivering the method at a national scale.
Regardless of whether mainstreaming
will be in the public, NGO, and/or private
sectors, this objective will influence
decisions on:

choice of delivery system or program
through which to provide the method.

design of the model for delivering ECPs
(i.e. who, where, which product, what
informational messages).

funding for commodity procurement and
delivery costs during and after the pilot
phase.
2. The pilot intervention should address
a felt need for the national program
and have the potential to meet
the needs of a substantially large
population. For example, reducing
unintended pregnancies and their adverse
consequences is a priority for most
health programs (including those due
to method failure). In Bangladesh, about
one-third of pregnancies every year are
unplanned, and it is believed that most of
these are terminated by unsafe abortion.
Policymakers and program managers
focused on the provision of methods
to reduce the incidence of unplanned
pregnancy. In Kenya, by contrast,
policymakers were concerned about
meeting the reproductive health needs of
the country’s large adolescent population.
Based on research demonstrating that
adolescents are the most frequent users
of ECPs, the MOH decided to strengthen
ECP provision to that target population
(Morgan 2007).
3. Delivery of ECPs in the national
program does not require major
changes in the existing system. The
prospect of having to make any major
change in the existing FP delivery system
will usually receive strong resistance
from policymakers and program mangers,
which reduces the likelihood of scaling
up. Thus, ECPs should be introduced as
one more option in the existing delivery
system for contraceptives. For example,
during introduction in Bangladesh, a onepage client registration form was supplied
for providers to complete. After six
months this form was dropped because of
the additional work required of providers;
they suggested adding a column to their
existing client register instead, and this
adjustment was used during nationwide
scale-up.
4. Program managers responsible for
scaling up ECP delivery should be
involved in planning and implementing
the pilot phase. It is easier to convince
those who will have decisionmaking
responsibility for planning and funding
the mainstreaming of ECPs, should the
pilot phase prove acceptable and feasible,
if they are fully aware of and support
the introductory model being piloted. If
program managers do not have the time
to get involved personally, they need
to be briefed regularly and encouraged
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to contribute ideas or administrative
support. In Ethiopia, turnover in the MOH
has frustrated mainstreaming efforts,
as original champions of ECPs were
replaced by less supportive officials. This
has stalled mainstreaming in the public
sector, although product registration
achieved under the pilot has enabled
expansion of ECP services in the country’s
private sector.
5. Build strategic partnerships with
organizations that can facilitate
mainstreaming. Depending on
the capabilities and resources of
the organization(s) supporting the
introductory and mainstreaming
processes, partnerships with agencies
that have specific technical expertise
or credibility and/or donors with
resources can be critical in successfully
implementing both stages. In Bangladesh,
with USAID funding, a group of
organizations supported the Directorate
General of Family Planning, including
Population Council, JSI, and Pathfinder
International. After its introduction,
UNFPA became the main funding partner
supporting the Government’s scale-up
program. In Kenya, the William and
Flora Hewlett Foundation is supporting
a national initiative to mainstream ECPs
in the public and private sectors. Under
this initiative, the Population Council has
partnered with PSI, Marie Stopes/Kenya,
the Pharmaceutical Society of Kenya,
various commercial distributors of ECP
products, and UNFPA.
6. Scale-up should be conducted in a
phased manner. Once a pilot project
has proven that ECPs and the model for
their delivery are acceptable and feasible,
it is not advisable to move immediately
to national level scale-up. Scaling up on
a gradual basis is recommended as the
immediate phase after piloting, as this
gives the opportunity to review, and adapt
and modify if necessary the procedures
and practices developed during the pilot
phase. This first phase of the scale-up
should be sufficiently large to learn about
and fully understand the operational and
management challenges of incorporating
ECPs into the existing systems and to
identify elements of the pilot model that
are not replicable and should be left out
(see diagram of the phased approach on
the next page).
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7. Careful planning and monitoring for
procurement and logistical supply
is essential. Logistical support is an
important foundation for efficient
ECP distribution, particularly during
introduction and scaling up. The more
common logistical problems experienced
by large delivery systems may include:
product registration and product
procurement from manufacturers;
poor distribution of ECP products or
IEC supplies to service delivery points;
or miscalculations of demand or
procurement, leading either to stock-outs
or over-stockages, resulting in expired
products. In Bangladesh, for example,
many facilities that received IEC materials
did not distribute them to potential
clients because experience with the public
logistics system led them to believe
that they would not get a re-supply on
time. In Kenya, the MOH received a large
consignment of ECP supplies prior to its
integration into the logistics system and
family planning registers; consequently,
the supplies were not distributed
systematically to provincial and district
levels, often reaching facilities with no
trained providers or procedures for
resupply (Keesbury, Owino, and Bradford
2007).
8. Plan and budget for long-term technical
assistance for the mainstreaming
process, preferably using personnel from
the pilot and/or limited scale-up phases.
The introduction of any new service into
a large delivery system requires some
adjustments and capacity building to
ensure its successful assimilation. Simply
communicating the finding that ECPs are
acceptable and describing the model by
which it was introduced and delivered to
program managers will not enable them
to adapt it into their systems. Sustained
technical assistance needs to be planned
and budgeted, using those familiar with
the ECP delivery model, until national
mainstreaming has been achieved.
Withdrawing technical assistance before
the method is fully mainstreamed can
lead to partial introduction and even
discontinuation of its provision. This was
the case in Ghana, where the Planned
Parenthood Association of Ghana (PPAG)
supported MOH efforts to introduce EC in
the public sector through a series of pilot
projects. The gains of this work, however,
have not been widely replicated due to
limited funding for PPAG’s continued
technical support and advocacy (Osei
2007).
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A phased approach to introducing and
scaling up ECP: The Bangladesh experience
.

Diagnostic studies: Qualitative needs assessment
for ECP services

.

OR to assess acceptability of ECPs and determine
operational mechanisms for introducing ECPs

.

Recommend appropriate strategies to the MOH
based on OR results

.

Presentation of OR results at the national level
to the media, program managers, researchers,
educationalists, and representatives of NGOs

.

Policy decision to introduce ECPs into the
National FP program in two phases

6.

Phase I: Introduction of ECPs in Dhaka division
covering a population of 45 million

7.

Development of IEC and training materials

8.

Training of 14,007 providers and provision of
services

9.

Monitoring of Phase I scale-up

10. Phase II: Scaled up in the remaining divisions,
covering a population of 89 million

. Continue monitoring and gathering feedback
from clients on service delivery

. Necessary measures taken to improve service
delivery and educate clients

9. Close monitoring of services at the initial
stage of mainstreaming has crucial
value. All components of a project or
initiative to introduce ECPs into a national
RH program (training, counseling,
distribution, and communication) need
systematic monitoring and documentation
for two equally important reasons: 1) to
ensure that the introductory activities
were implemented as planned and
are functioning efficiently; and 2) to
have a record of the facilitating factors
and obstacles encountered during the
introductory process so that appropriate
action can be taken when scaling up
and mainstreaming these introductory
experiences. Monitoring training and
developing support systems can be used
to provide feedback so that plans for
training after mainstreaming is complete
can be based on these experiences.
Routine monitoring using MIS data can

provide feedback once ECPs have been
integrated into the family planning
delivery system. These data can be used
to identify service delivery points that
need more training, supervision, or
strengthening in general. Conducting
rapid mid-term monitoring assessments
(for example, after six months of service
provision) can be useful to assess the
quality of services provided—for example,
whether new knowledge and skills have
been retained.
10. Monitoring and occasional evaluation
must be sustained once mainstreaming
has been achieved. Three indicators can
be used to determine when ECPs have
been successfully mainstreamed in the
system:

Inclusion of ECP products in the public
health system’s essential commodities
list so that there is a regular line item in
the contraceptive procurement budget.

Inclusion of ECPs in the national
contraceptive MIS system, which shows a
commitment to monitor the performance
of the program in terms of its capacity to
deliver ECPs.

Documenting the number and proportion
of providers and facilities reporting that
stock and distribute or sell ECPs as one
of their standard services or products.
Monitoring should continue after the
delivery of ECPs has been fully assimilated
into public health, private, or NGO
delivery systems. At this point the focus
of monitoring shifts from documenting
implementation of introductory activities
to routinely measuring the delivery of
ECPs as one FP service within the overall
RH program. Special periodic surveys
can provide important data on program
performance–for example, through
inclusion of questions or modules on ECPs
in national and district-wide reproductive
health surveys. In Kenya, such a survey
was undertaken after nearly a decade of
ECP service provision, allowing program
managers to reflect on the success of
their efforts and reorient strategies
where necessary (Keesbury, Owino, and
Bradford 2007). Furthermore, data on
the bridging role of ECPs to increase
regular use of FP will support recognition
of ECP introduction and mainstreaming
as an important reproductive health
intervention.
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